HHL provides facilities services to the Wellcome Trust's human genome research facility. The nature of the site means that a reliable and stable power supply is vital. Dalkia's solution is a 2MWe CHP unit, which it will operate and maintain in order to maximise energy efficient heat and power production onsite for the facility. The CHP plant will save around 3,100 tonnes of CO2 emissions each year.
The Wellcome Trust is one of the biggest medical funding charities in the world. It therefore has an obligation to advance general scientific and medical awareness. With this in mind HHL support both the Wellcome Trust's own research as well as providing facilities for conferences, seminars and training at the human genome campus.
HHL therefore has a significant demand for heat and power across the site. In addition the research laboratories themselves demand a stable and un-interrupted supply of electricity that will support the delicate processes being undertaken there.
Dalkia has designed and installed a CHP unit alongside an absorption chiller, modern and efficient ancillary plant, a modular plant room and a cooling tower. Its expertise means that organisations can call upon Dalkia to undertake a full site audit, to ascertain the energy demands and viability for onsite CHP technology. Dalkia can then design the plant and install and commission it, before operating and providing 24-hour surveillance via its service centre and mobile engineer network.